Worldwide known physician Dr. David Samadi has performed thousands of surgeries over 45 different countries. With his studies at Stony Brook University and Stony Brook School of Medicine, he obtained his degree in biochemistry and medicine. With postgraduate work Dr. David Samadi was about to further his skills to eventually become the current Chairman of Urology and Chief of Robotic Surgery at Lenox Hill Hospital in New York, NY. His is board certified as a urologist. With advance study in recognizing and providing aid for urologic diseases, cancers of the prostate, kidney, and bladder. His skill set has allowed him to perform advanced procedures by hand or via robotic intervention.
Dr. Samadi has invented his own procedure called the SMART method. Samadi Modified Advanced Robotic Technique. Most surgeons use a particular method in his field of urology to remove a damaged prostate. Upon doing so causes tons of nerves damage leaving many men with incontinence and impotence. Men often refuse to have this procedure done with fear of losing a part of themselves. Looking into the matter himself, Dr. Samadi developed this technique with the purpose of reducing nerve damage during the surgery. With so many nerves still intact from the SMART procedure, Dr. Samadi has opened up a solution on two fronts for men with prostate issues. They can keep their fervor while removing a toxic portion of their body.
He constantly strives to change the lives of not just men, but all people. Dr. David Samadi hosted during the years of 2011 and 2016 a show on Fox News called “Sunday Housecall.” This show took news and information to people across the globe. Instead of settling for patients in his office, he sought to give health related news to all people that could contact the show. He would even take questions and concerns from his viewers to ensure that questions and difficulties people were facing were being addressed via his intellect.
Dr. David Samadi does not only commit his time and energy to fixing the body, or hosting television shows. Dr. Samadi does talks and interviews. He seeks to encourage and uplift all of those within his sphere of influence. A book he recommends during his interview with Ideamensch is to read “Anything is Possible” by Elizabeth Strout. A collection of inspiring stories. He even recommends investing tips in technologies as they will only continue to grow and advance.
The burden of prostate cancer in society is substantial and has increased since the PSA testing was introduced, but patients often question should you go with surgery or radiation to treat this disease. Dr. David Samadi, leading expert and Chairman of Urology at Lenox Hill Hospital dedicated a full show on his morning radio broadcast, and has a Youtube video discussing the benefits of surgery vs radiation.There are various alternative therapies available for the treatment. Depending on the stage of the disease, surgery, radiotherapy, and in some cases, simply waiting may be used. Especially in older patients, postponing the treatment to a later date is a possible alternative. For patients it is often not easy to decide on a therapy. Especially between surgery and radiotherapy, many factors often influence the decision-making process, but Dr. David Samadi says surgery is by far a better choice than radiation.
Several studies have examined both procedures and concluded that between surgery and radiotherapy, there was a clear benefit to operation versus radiotherapy. Dr. Samadi addressed this question on his radio broadcast, and he remarked that “with surgery, the outcome is great…and radiation should be considered a Plan B.”Also with surgery, there is a shorter recovery time. Doctors also note that when treating a prostate carcinoma, there are also different stages that may require a different treatment method. Family history also plays a role in determining the best treatment method. It appears that prostate cancer patients with family history may have a worse outcome after treatments by radiotherapy prostatectomy compared with patients without a family history.Genetic factors are also responsible in 5 to 10 percent of prostate cancer cases, and in this scenario, patients often opt for surgery.
The hardship of prostate cancer will increase due to our aging population.A clear understanding of risk factors, including factors like family history, race, and aging, and diet and environmental agents will help design strategies for the best treatment, not to mention diminish risk.Dr. David Samadi has been researching and treating urological diseases like prostate cancer for nearly two decades. Born in Iran, Dr. Samadi and his family immigrated to the United States where he attended high school then Stony Brook University in New York. After earnin his Bachelor’s and Medical degrees he completed his residency at local New York hospitals.Dr. Samadi developed the groundbreaking SMART surgery technique, and today is a internationally recognized surgeon, based in New York where he heads the Urology department at Lenox Hill Hospital.
Clay Siegall is a M.D. and CEO who has an interest in all things medical. Clay Siegall recently released a blog post detailing the dire medical needs of the U.S. Virgin Islands. Clay Siegal explains how the U.S. Virgin Islands have failed to keep up with modern medical advances, and he describes a number of ways this problem can be addressed.
Clay Siegall details how the effects of the recent hurricanes have left the islands in a dire state. The U.S. Virgin Islands were devastated by hurricane Maria with some of the islands being completely evacuated. The hurricanes resulted in electrical outages that persisted for months with many of the areas medical professionals deciding to not travel back to the U.S. Virgin Islands. In addition, the islands have experienced a lack of safe drinking water and shortages of medicine. Clay Siegall also observes that the hurricane resulted in a massive mosquito problem that has resulted in tropical diseases. Clay Siegall calls for an increased focus on the U.S. Virgin islands.
Dr. Clay Siegall holds a Ph.D. in genetics from George Washington University. He worked in research before co-founding Seattle Genetics. The company combines aggressive investment and research strategies to bring antibiotic derived genetic therapies to fight cancer. These drugs are designed to work with a specific patient that is receiving a specific combination of medications. This allows for cancer therapies with lower adverse drug reactions. Dr. Clay Siegall has been able to raise 675 million dollars for this company. Seattle Genetics went public in 2001.